Increased late hepatic artery thrombosis rate and decreased graft survival after liver transplants with zero cross-reactive group mismatches
Open Access
- 1 March 2000
- journal article
- research article
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 6 (2) , 229-236
Abstract
The use of broad-specificity cross-reactive groups (CREGs) at the A and B HLA loci has been proposed as a means to improve both access and outcome for renal transplantation but has not yet been studied for liver transplantation. We retrospectively analyzed our results for all adult liver transplantations performed at our center between 1989 and 1996 for which HLA typing and complete 3-year follow-up data were available. Two hundred eight transplantations were studied, with a mean follow-up of 66 ± 2 months (range, 36 to 110 months); A and B loci were converted to CREGs by the method of Rodey. Thirteen percent of the patients with 0 CREG mismatches had hepatic artery thrombosis versus 2% for those with 1 or more mismatches (odds ratio, 6.7; 95% confidence interval, 2.6 to 17.3 by univariate analysis; odds ratio, 3.5; 95% confidence interval, 1.1 to 11.7 by logistic regression analysis). These events occurred significantly later in the 0-CREG mismatch group (21 ± 7 v 4 ± 2 months posttransplantation; P = .04 by Student’s t-test). Graft survival rates were significantly lower for patients with 0 CREG mismatches (56% v 68% at end of study; P = .05 by Cox-Mantel test). The number of CREG mismatches had no effect on the frequency of rejection, steroid-resistant rejection, or infectious complications, including cytomegalovirus. Neither total nor individual A, B, or DR HLA matching had an effect on outcome. There appears to be little evidence that intentional CREG matching would improve outcomes for liver transplantation and, under some circumstances, could be deleterious.Keywords
This publication has 26 references indexed in Scilit:
- EFFECT OF PARTIAL HLA CLASS I MATCH ON ACUTE REJECTION IN VIRAL PRE-INFECTED HUMAN LIVER ALLOGRAFT RECIPIENTS1Transplantation, 1998
- Low-dose aspirin therapy is associated with few side effects but does not prevent hepatic artery thrombosis in liver transplant recipientsLiver Transplantation and Surgery, 1997
- REPEAT HLA-B AND -DR LOCI MISMATCHING AT SECOND LIVER TRANSPLANTATION IMPROVES PATIENT SURVIVALTransplantation, 1996
- LATE ACUTE FAILURE OF WELL-HLA-MATCHED RENAL ALLOGRAFTS WITH CAPILLARY CONGESTION AND ARTERIOLAR THROMBITransplantation, 1995
- HLA COMPATIBILITY AND LIVER TRANSPLANT OUTCOME Improved Patient Survival by HLA and Cross-MatchingTransplantation, 1994
- Epitope specificity of HLA class I alloantibodies I. Frequency analysis of antibodies to private versus public specificities in potential transplant recipientsHuman Immunology, 1994
- PROLONGED PRESERVATION IN UNIVERSITY OF WISCONSIN SOLUTION ASSOCIATED WITH HEPATIC ARTERY THROMBOSIS AFTER ORTHOTOPIC LIVER TRANSPLANTATIONTransplantation, 1993
- Influence of human leukocyte antigen matching on liver allograft survival and rejection: “The dualistic effect”Hepatology, 1993
- HEPATIC ALLOGRAFT RESCUE FOLLOWING ARTERIAL THROMBOSIS: ROLE OF URGENT REVASCULARIZATIONTransplantation, 1991
- THE EFFECT OF HLA-A, -B MATCHING ON CADAVER RENAL ALLOGRAFT REJECTION COMPARING PUBLIC AND PRIVATE SPECIFICITIESTransplantation, 1984